These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10363620)

  • 1. Pharmacokinetics and bioavailability of the flavonol quercetin in humans.
    Graefe EU; Derendorf H; Veit M
    Int J Clin Pharmacol Ther; 1999 May; 37(5):219-33. PubMed ID: 10363620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats.
    Hou YC; Chao PD; Ho HJ; Wen CC; Hsiu SL
    J Pharm Pharmacol; 2003 Feb; 55(2):199-203. PubMed ID: 12631412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral bioavailability of quercetin from different quercetin glycosides in dogs.
    Reinboth M; Wolffram S; Abraham G; Ungemach FR; Cermak R
    Br J Nutr; 2010 Jul; 104(2):198-203. PubMed ID: 20230651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary flavonoids as antioxidants in vivo: conjugated metabolites of (-)-epicatechin and quercetin participate in antioxidative defense in blood plasma.
    Terao J
    J Med Invest; 1999 Aug; 46(3-4):159-68. PubMed ID: 10687310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the flavonol quercetin on the bioavailability of simvastatin in pigs.
    Cermak R; Wein S; Wolffram S; Langguth P
    Eur J Pharm Sci; 2009 Dec; 38(5):519-24. PubMed ID: 19804821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
    Li XB; Wu WX; Su D; Wang ZJ; Jiang HY; Shen JZ
    J Vet Pharmacol Ther; 2008 Dec; 31(6):523-7. PubMed ID: 19000274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
    Hosagrahara VP; Chandrasena G; Chang SY; Koplowitz B; Hariharan N; Cheng PT; Humphreys WG
    Xenobiotica; 2006 Dec; 36(12):1227-38. PubMed ID: 17162469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of the bioflavonoid biochanin A: effects of quercetin and EGCG on biochanin A disposition in rats.
    Moon YJ; Morris ME
    Mol Pharm; 2007; 4(6):865-72. PubMed ID: 17970592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-administration of quercetin and catechin in rats alters their absorption but not their metabolism.
    Silberberg M; Morand C; Manach C; Scalbert A; Remesy C
    Life Sci; 2005 Nov; 77(25):3156-67. PubMed ID: 15979103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating mass balance for inhaled drugs in humans: an example with a VLA-4 antagonist, IVL745.
    Rohatagi S; Shah B; Zhang J; Zeng Z; Kirkesseli S; Jensen BK
    J Clin Pharmacol; 2004 Apr; 44(4):348-58. PubMed ID: 15051741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM; Perkins J
    J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantiomeric disposition of ketorolac in goats following administration of a single intravenous and oral dose.
    Nagilla R; Deshmukh DD; Copedge KJ; Miller S; Martin B; Bell EC; Duran SH; Ravis WR
    J Vet Pharmacol Ther; 2009 Feb; 32(1):49-55. PubMed ID: 19161455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacokinetics of 3H-bamethan in humans].
    Hengstmann JH; Steinkamp B
    Arzneimittelforschung; 1981; 31(5):843-8. PubMed ID: 6115653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of enrofloxacin in Korean catfish (Silurus asotus).
    Kim MS; Lim JH; Park BK; Hwang YH; Yun HI
    J Vet Pharmacol Ther; 2006 Oct; 29(5):397-402. PubMed ID: 16958784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of marbofloxacin after single intravenous and repeat oral administration to cats.
    Albarellos GA; Montoya L; Landoni MF
    Vet J; 2005 Sep; 170(2):222-9. PubMed ID: 16129342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.